Skip to main content
. 2015 Nov;185(11):2949–2968. doi: 10.1016/j.ajpath.2015.07.010

Table 2.

Treatment-Related Differences in Genes Suppressed during Infection

Gene name Gene symbol Infected vehicle Anti-Ang2 antibody, % Anti-TNF antibody, % Antibody combination, %
Anti-Ang2 antibody: suppression of smaller expression increases during infection
 Eph receptor A4 Epha4 1.3 −115 −180 −179
 Fibulin 2 Fbln2 1.4 −70 −117 −128
 Fibrillin 1 Fbn1 1.4 −51 −66 −77
 Serpin B2 Serpinb2 1.5 −86 −4 −97
 Follistatin Fst 1.5 −72 −64 −100
 Neurotensin Nts 2.1 −77 −67 −81
 Von Willebrand factor Vwf 2.2 −58 −89 −111
 Chemokine (C-C motif) receptor 2 Ccr2 2.3 −61 76 −27
 Selectin, endothelial cell Sele 4.7 −50 −70 −91
 Prokineticin 2 Prok2 6.0 −74 −95 −96
Anti-TNF antibody and antibody combination: suppression of largest increases with infection
 Selectin, platelet Selp 16.6 −37 −74 −83
 Pro-platelet basic protein Ppbp 18.6 30 −80 −89
 Colony-stimulating factor 3 receptor Csf3r 19.5 13 −45 −74
 Schlafen 1 Slfn1 19.7 18 −21 −57
 Matrix metallopeptidase 8 Mmp8 20.3 −30 −83 −94
 Matrix metallopeptidase 3 Mmp3 23.5 −5 −58 −63
 Chemokine (C-C motif) receptor 1 Ccr1 24.2 −7 −24 −50
 Chemokine (C-X-C motif) ligand 1 Cxcl1 26.2 −8 −46 −67
 Formyl peptide receptor 1 Fpr1 27.9 0 −76 −93
 Pleckstrin Plek 31.9 5 −38 −67
 Sclafen 3 Slfn3 49.9 10 −49 −83
 Chemokine (C-X-C motif) ligand 10 Cxcl10 56.7 0 −38 −68
 IL-1 receptor antagonist Il1rn 60.0 6 −42 −77
 Chemokine (C-C motif) ligand 3 Ccl3 68.6 28 −52 −82
 Formyl peptide receptor 2 Fpr2 79.0 12 −59 −83
 Chemokine (C-X-C motif) ligand 3 Cxcl3 83.6 −18 −79 −86
 C-type lectin domain family 4d Clec4d 87.8 10 −50 −80
 C-type lectin domain family 4e Clec4e 124.3 14 −50 −85
 IL-1β Il1b 127.9 2 −42 −75
 Serum amyloid A3 Saa3 198.8 0 −64 −62
 Schlafen 4 Slfn4 203.3 5 −51 −72
 Immunoresponsive gene 1 Irg1 229.2 7 −53 −78
 Chemokine (C-X-C motif) ligand 2 Cxcl2 280.5 4 −55 −75
 S100 calcium binding protein A8 S100a8 282.7 −10 −61 −79
 S100 calcium binding protein A9 S100a9 324.3 −8 −54 −78

Genes with the largest increases during Mycoplasma pulmonis infection (7 days; condition A) ranked by fold increase from pathogen free. Genes included had at least one treatment reduce expression by 50% or more. Treatment with anti-Ang2 antibody alone suppressed genes that underwent more modest increases after infection than with anti-TNF antibody or antibody combination. More negative values indicate greater suppression of the infection-induced increase in expression. A value of −100% indicates complete suppression of the increase, and values <−100% indicate suppression of expression to lower than the pathogen-free level.

Ang2, angiopoietin-2; TNF, tumor necrosis factor.